Beyond the knockout: using Cre-lox technology to model cancer, neurodegenerative diseases and more

Cre-lox technology is widely used to create traditional, tissue-specific, and inducible models. The technology also is a powerful tool for creating sophisticated models of specific human cancers and other human diseases. 

In this webinar you will learn:

• How Cre-lox technology is being used to model various human cancers, including early malignancy in lung adenocarcinoma, breast cancer and melanoma 
• How Cre-lox technology is furthering our understanding of Amyotrophic Lateral Sclerosis (ALS), Parkinson’s Disease and other neurodegenerative disorders 
• How Cre-reporter strains can be used to label specific cell populations and in mosaic and lineage tracing analyses

Presenter: Peter Kelmenson, Technical Information Scientist